Objectives. Previous research demonstrated decreased cardiorespiratory fitness (CRF) in patients with JDM during active disease and remission. However, longitudinal data regarding trajectories of CRF are currently lacking. The objective of this study was to determine trajectories of CRF in patients with both monocyclic and chronic JDM, and to identify potential predictors of these trajectories.
Introduction JDM is a rare systemic autoimmune vasculopathy characterized by capillary inflammation that affects predominantly the musculoskeletal and cutaneous systems [1] . Prominent clinical features include muscle weakness [2] , reduced cardiorespiratory fitness (CRF) [38] and fatigue [9] , even in clinical remission. The disease course is heterogeneous, varying from mild muscle symptoms that promptly respond to pharmacological treatment to a prolonged treatment-resistant chronic course [10] . Long-term outcomes have indicated that patients with a chronic JDM course display greater degrees of functional disability, muscle weakness and disease damage, as well as more frequent calcinosis and lipodystrophy compared with patients with a monocyclic course [1115] .
Clinical assessment, interpretation and evaluation of CRF is an important element in the care of patients with JDM, as it is an important marker of health that has been inversely associated with cardiovascular risk factors in children and adolescents [16, 17] . For example, in children and adolescents with congenital heart or lung disease, aerobic capacity is a prognostic factor for morbidity and mortality [1821] . Diminished CRF in the active phase of JDM might be explained by biological processes of the disease itself, such as thickened capillary endothelium, decreased capillary bed volume and impaired perfusion/ oxygenation. Furthermore, CRF is indirectly affected by sedentary lifestyle [5, 22, 23] and corticosteroid treatment. Steroid treatment has been shown to induce myopathy [24, 25] . In addition to reduced CRF in the active phase of JDM, as seen in cross-sectional studies [3, 4, 7] , a small number of studies also showed decreased CRF during remission [8, 26] . Type of JDM, prolonged treatment, disease duration, diagnostic delay and age of onset might explain inter-individual differences in CRF. However, longitudinal data regarding trajectories of CRF and its predictors are currently not available. These data are vital to provide relevant clinical information concerning the need for additional physical activity or exercise training in the follow-up of this population. Furthermore, these data will help to inform newly diagnosed patients about the expected disease course and side effects of treatment. Therefore, the aim of the current study was to determine, for the first time, trajectories of CRF in patients with both monocyclic and chronic JDM compared with healthy children, and to examine potential predictors of these trajectories.
Methods

Patients
All patients diagnosed with JDM in the paediatric rheumatology outpatient clinic of the Wilhelmina Children's Hospital, University Medical Centre Utrecht, the Netherlands, who performed a cardiopulmonary exercise test (CPET) at least twice up to 10 years after diagnosis, between 2003 and 2016 were included. Only two of all our patients could not be included in the analysis as they were recently diagnosed with JDM and therefore were tested only once. The youngest patient was 6 years of age at their first CPET. Patients were all diagnosed with JDM by a paediatric rheumatologist/immunologist according to Bohan and Peter criteria [27, 28] . Patients were classified into two groups of disease course: monocyclic and chronic. Polycyclic patients in our clinic all eventually proved to have a mixed connective tissue disease phenotype and were therefore excluded. Monocyclic is defined as remission within 23 years after diagnosis without relapse and medication use, and chronic is defined as unable to retrieve remission within 23 years of diagnosis [29] . Clinical remission was defined by the Paediatric Rheumatology International Trials Organisation (PRINTO) criteria [30] . The study was approved by the medical ethics committee of University Medical Centre Utrecht (17-008/C). For this study, only de-identified patient data were used that were collected during standard patient care. The Dutch Medical Research involving Human Subjects Act (WMO) does not apply to these types of studies. According to Dutch law, de-identified patient data may be used for research purposes, without informed consent of the patient.
Retrospective data collection
Medication history, information regarding disease onset and disease course were collected from the medical records. Diagnostic delay was defined as the time from first symptoms to the moment of diagnosis. The disease duration was defined as the time from onset of symptoms until clinical remission on medication. Patients were divided into four groups based on prednisone dose 3 months prior to CPET: none, low (<0.5 mg/kg/day), medium (0.51.0 mg/kg/day) and high (>1.0 mg/kg/day). The prednisone free period was defined as the difference in time between discontinuation of prednisone use and time of CPET.
Anthropometry
Body mass and height were assessed with an electronic scale (Seca, Birmingham, UK) and a stadiometer (Ulmer, Prof. E. Heinze, Ulm, Germany), respectively. BMI Z-scores were calculated using age-and sexmatched Dutch reference values from the national Dutch anthropometric reference database for professionals [31] .
Cardiopulmonary exercise test
In all patients, CRF was assessed during a CPET on an electronically braked cycle ergometer (Lode, Corival, ProCare B.V. Groningen, the Netherlands). After assessment of baseline cardiopulmonary values during a 2-min resting period, patients were asked to start unloaded cycling (0 W) for a minimum of 2 min (warm-up phase). Hereafter, work rate was increased linearly every second, instead of each minute, in order to determine the patient's maximal workload more precisely. Constant increments of work rate of 10, 15 or 20 W/min were selected based on the patient's body height (<125 cm, between 125 and 150 and >150 cm, respectively), as per the ramp version of the Godfrey protocol [32, 33] , and based on current disease status of the individual patient. The protocol continued until the patient's pedalling frequency consistently fell below 60 revolutions/minute, despite strong verbal encouragement. During the test, ventilatory gas exchange data were determined breath-by-breath. Absolute peak oxygen consumption (VO 2peak ) was taken as the average value over the last 30 s of the CPET.
The VO 2 at ventilatory anaerobic threshold (VO 2 VAT) was determined by a trained clinical paediatric exercise physiologist using the criteria of an increase in both the ventilatory equivalent of oxygen (VE/VO 2 ) and end-tidal pressure of oxygen (PETO 2 ) with no increase in the ventilatory equivalent of carbon dioxide (VE/VCO 2 ). Furthermore, the mechanical efficacy (ÁO 2 /W peak ) was calculated. A test was considered to be at maximal level when at least one of the following criteria was met: a heart rate at peak exercise (HR peak ) of >95% of predicted for age and gender and/or a respiratory exchange ratio at peak exercise of >1.00 [34] . CRF values were compared with age-and sex-matched Dutch reference values for paediatric cardiopulmonary testing in order to determine Z-scores [33] .
Statistical analysis SPSS Statistics for Windows, version 20.0 (IBM Corp, Armonk, NY, USA) was used for descriptive statistics. Multilevel modelling with the multilevel programme MLwiN 2.23 (Centre for Multilevel Modelling, University of Bristol, Bristol, UK) was applied to analyse longitudinal changes in CRF parameters. In multilevel models, longitudinal data, which are not independent and nested, within patients can be analysed. An advantage of multilevel modelling is that all of the available results can be incorporated within the analysis, even if the number of measurements and temporal spacing of measurements may vary between patients, assuming that the missing data are random [35, 36] . A two-level multilevel structure was applied: level 1 represented repeated measures within patients, and level 2 represented the patients. First, multilevel models were created to examine the changes over time in the CRF values aerobic capacity, maximal workload, mechanical efficacy and VO 2 at ventilatory anaerobic threshold. Categories were created to analyse the trajectories of the patients after diagnosis. The reference value was defined as the group that was tested within 1 year after diagnosis (t 0 ). The subsequent groups that were created were: 12 years after diagnosis (t 1 ), 24 years after diagnosis (t 2 ), 46 years after diagnosis (t 3 ), 68 years after diagnosis (t 4 ) and 810 years after diagnosis (t 5 ). The time between two assessments was at least 0.7 years. If the patient had more than one measurement in one of the aforementioned groups, only the first measurement was used. For all four models the dependent variable (VO 2peak , W peak , ÁO 2 /W peak , VO 2 VAT) was represented by the term y ij where the subscripts indicate an observation of repeated measures (i) within patients (j). b 0 is the average intercept, the average score of the test within the first year after diagnosis for all patients. The u 0j is the deviation of the intercept of a patient from the average (b 0 ), the multilevel model allowed for varying between patients. In addition e 0ij is the deviation between measurements. To predict the time trajectories, the explanatory variable (time groups) are added to the model, which is denoted as x 1ij with fixed regression coefficient b 1 . The final model is expressed by the equation:
Predictions were calculated based on the equation.
A second analysis was used to determine possible predictors of the CRF. The analyses for predicting the trajectories and determining possible predictors were separated because entering the group categories for analysing the trajectories reduced the amount of data that could be used. Some of the patients had more than one measurement in each of the aforementioned groups (i.e. >1 measurement within the outlined time frame). At first the continuous variable time between diagnosis and testing was included in the models to maintain the longitudinal data structure. Potential predictors of CRF were type of JDM, disease duration, age of onset, diagnostic delay, prednisone dose and prednisone-free period. These predictors were entered in the order listed to find the best model fit. Random intercepts and random slopes were considered allowing for unique intercept for each patient and properly accounting for correlations among repeated measurements within patients [36] . Model fit was evaluated by comparing the À2log likelihood (deviance) of the empty (most simple) model, with a more complex model including predictors. Deviance is a measure of how well the model fits the data or how much the actual data deviate from the predictors of the model. A simpler model can be rejected with a decrease in the deviance and a P < 0.05. The final model is compared with the empty model on its À2log likelihood. An a of 0.05 was adopted for all tests of significance.
Results
Patient characteristics
Thirty-six patients were tested on average 5 (29) times between 2003 and 2016. The demographic characteristics of the study population are depicted in Table 1 .
Trajectory of CRF
The predicted trajectories based on multilevel models of absolute aerobic capacity, absolute maximal workload, mechanical efficacy and absolute oxygen uptake at ventilatory anaerobic threshold (VO 2 VAT) as Z-scores are shown in Fig. 1AD , respectively.
Aerobic capacity
The predicted value for absolute aerobic capacity within the first year after diagnosis deviated À2.77 S.D. from the reference values of healthy children, indicating that aerobic capacity in patients during active disease is significantly reduced. In the years thereafter, patients showed substantial improvement compared with the first year after diagnosis; however, they did not reach normal levels within the 10 years of follow-up. After 46 years, the initial improvements seemed to halt, and absolute aerobic capacity decreased between 6 and 10 years after diagnosis.
Maximal workload
The predicted value for absolute maximal workload within the first year after diagnosis deviated À2.77 S.D. from the reference values. The following 6 years showed improvement of absolute maximal workload over time, with the largest improvement the second year after diagnosis. Despite the improvement, the absolute maximal workload did not reach normal levels, and even decreased again 8 years after diagnosis.
Mechanical efficiency
The final model including time categories was not significantly stronger than the empty model; however, the estimated improvements in mechanical efficiency for 26 years after diagnosis were significant compared with t 0 . Within the first year after diagnosis, the predicted value for mechanical efficiency deviated À1.04 S.D. from the reference values. Patients showed significant improvement in the following years, reaching normal values within 4 years after diagnosis. However, after 46 years the mechanical efficiency decreased.
Oxygen uptake at ventilatory anaerobic threshold
The predicted value for absolute VO 2 VAT within the first year after diagnosis deviated À1.97 S.D. from the reference values. In the following 3 years, patients showed a gradual improvement in VO 2 VAT. However, after the first 4 years VO 2 VAT decreased again to values similar to those observed 12 years after diagnosis. Only a slight improvement was observed after 810 years.
Predictors within trajectories CRF
Output estimates for the final multilevel models including predictors (type of JDM, disease duration, age of onset, diagnostic delay, prednisone dose and prednisone free period) for absolute aerobic capacity, absolute maximal workload, mechanical efficacy and absolute VO 2 VAT as Z-scores are shown in Tables 25, respectively.
Aerobic capacity
The predictors disease duration, age of onset and prednisone dose significantly improved the model for absolute aerobic capacity (P < 0.05), shown in Table 2 . Longer disease duration decreased the predicted outcome with À0.43 S.D. per year from healthy children. Being older at disease onset positively influenced the absolute aerobic capacity. For every year older at onset an increase of 0.20 in Z-score was estimated. A low (<0.5 mg/kg), medium (0.51.0 mg/kg) or high (>1.0 mg/kg) prednisone dose led to a lower absolute aerobic capacity compared with no prednisone use, with a decrease in Z-score of À0.15 (low), À1.04 (medium) and À1.33 (high). Including type of JDM did not lead to a stronger model, which indicates that no significant differences exist between the trajectories of monocyclic and chronic JDM. Neither diagnostic delay nor prednisone-free days improved the model and, therefore, were not included in the final model.
Maximal workload
Disease duration, age of onset and prednisone dose significantly improved the model for absolute maximal workload (P < 0.05), as shown in Table 3 . Longer disease duration had a negative effect on maximal workload: for every year of active disease the predicted absolute maximal workload decreased with À0.62 S.D. Being older at onset of the disease was beneficial for the predicted absolute maximal workload, with an estimated increase of 0.16 S.D./year. A low (<0.5 mg/kg), medium (0.51.0 mg/kg) or high (>1.0 mg/kg) prednisone dose in the months before the test led to a lower absolute maximal workload with a decrease in Z-score of À0.02 (low), À1.13 (medium) and À4.03 (high) compared with no prednisone use. Type of JDM, diagnostic delay and prednisone-free days did not improve the model and, therefore, were not included in the final model.
Mechanical efficiency
The predictors age of onset and prednisone dose significantly improved the model for mechanical efficiency (P < 0.05), shown in Table 4 . Concordant with the results for aerobic capacity and maximal workload, being older at onset of the disease was beneficial for the predicted outcome, with an increase of 0.12 S.D./year. The use of prednisone had a negative effect on the outcome with a decrease in Z-score of À0.69 (low), À1.30 (medium) and À1.42 (high) prednisone dose compared with no prednisone. The other variables did not significantly predict mean power on the mechanical efficiency and were thus not included.
Oxygen uptake at ventilatory anaerobic threshold
Disease duration and age of onset significantly (P < 0.05) improved the model for absolute VO 2 VAT, shown in Table 5 . As also observed for aerobic capacity and maximal workload, a longer active disease period decreased the outcome of the absolute VO 2 VAT with À0.4 S.D. for every year of active disease. Being older at onset of the disease improved the predicted outcome, with an increase of 0.10 S.D. for every year. Type of JDM, diagnostic delay, prednisone dose and prednisone-free days, did not improve the model and were not included in the final model. https://academic.oup.com/rheumatology
Discussion
Our aim was to investigate trajectories of CRF in patients with both monocyclic and chronic JDM, from diagnosis up to 10 years after diagnosis, and to identify potential predictors of these trajectories. CRF was significantly decreased in patients with JDM during the active phase of the disease compared with healthy children. This is in line with earlier cross-sectional studies [3, 4, 6, 7] . Both monocyclic and chronic patients with JDM showed initial improvement of CRF during the first years ($5 years) after diagnosis, probably due to effects of pharmacological treatment and biological recuperation. However, after this initial recovery phase, on the group level no further improvements (plateauing) and even decreases in CRF were observed. Although a decreased aerobic capacity 10 years after remission, was also found in the cross-sectional study of Mathiesen et al. [8] , long-term trajectories of CRF after diagnosis have not been studied before in patients with JDM. Type of JDM was also included in the multilevel models to examine its impact on the observed trajectories. Our findings suggest that there is insufficient FIG. 1 The predicted trajectories of CRF based on multilevel models
Output estimates for the prediction models of aerobic capacity (A), maximal workload (B), mechanical efficiency (C) and oxygen uptake at ventilatory anaerobic threshold (VO 2 VAT) (D). Estimated values representing Z-scores compared with healthy children for every time group. P-values are shown relative to t 0 (01 years). The best model is expressed by the equation (y ij ). evidence to support an effect of type of JDM on CRF trajectories. Separate trajectories for monocyclic and chronic JDM were analysed but not included in the current article due to lack of power. However, separate analyses indicate that trajectories are comparable across these two types of JDM. Although the absolute CRF outcomes are higher in patients with monocyclic compared with chronic JDM presentation, both types demonstrate lower CRF compared with healthy children. Unexpectedly, we found decreased CRF trajectories not only in chronic but also in monocyclic patients during long-term follow-up. This indicates that muscle impairment in this group may be worse than expected, despite initial mild muscle symptoms and prompt response to pharmacological treatment. Clinically, this is a well-recognized phenomenon, as (physical) work-related problems in older patients are also frequently experienced in monocyclic patients. Our results underscore the importance of regular evaluation of CRF in long-term follow-up, even of monocyclic patients. In addition to classical inflammatory and functional outcome, different exercise-related parameters should be tested as an important marker of health. Furthermore, the decreased CRF trajectories suggest that interventions targeting physical training should become an integrated part of regular care and long-term follow-up [37] . The plateau phase (45 years after diagnosis) may be a particularly relevant and sensitive window of opportunity for intervention to stimulate further improvement towards normal values and to prevent (further) decrease of CRF. Individualized physical exercise training increases the capacity of the pulmonary, cardiovascular, haematopoietic, neuromuscular, musculoskeletal and metabolic systems, and thus, may greatly impact CRF [38, 39] . Some of the paediatric patients included in this evaluation (n = 8) participated in a randomized controlled trial studying the effects of physical training in JDM [38] . These patients all showed an increase in CRF due to the exercise intervention, a finding that bolsters the efficacy of training in this population.
Our multilevel analysis of possible predictors indicates that longer disease duration, younger age of onset, and higher prednisone dose significantly deteriorate the longterm outcome of CRF. The longer active disease duration might negatively impact CRF via the direct damage of the disease processes that initiate endothelial damage. Vasculopathy of the microvasculature is a pathophysiological hallmark of JDM, inducing loss of capillaries in the muscle [8, 11, 40] . Capillary involvement in the active phase of the disease is substantiated by the clear presence of the membrane attack complex in the capillaries [4144] , as well as signs of active neovascularization in the muscle tissue [45] . Capillary damage or destruction may lead to disturbed perfusion of the muscle tissue, [5, 26, 4547] . Impaired blood supply affects the oxygen transport to the exercising muscle tissue, which disturbs aerobic metabolism during exercise, and therefore, CRF. This contributes to impaired muscle function in the long term. Additionally, an earlier study from our research group [46] demonstrated that patients with JDM experience difficulties in increasing blood volume during strenuous exercise. Taken together, these findings support the existing hypothesis of partial recovery of musculoskeletal systems in JDM, as no evident cardiac and/or pulmonary limitations were found in the current study. The negative dose-dependent effect of prednisone may be a result of the side effects of this medication. Indeed, a well-known side effect is prednisone myopathy, caused by changes in protein metabolism resulting in muscular atrophy [4850] . A lower and impaired muscle mass can consequently lead to lower absolute aerobic capacity and maximal workload. The international consensus guidelines for treatment of patients with JDM recommend a high dose of prednisone as initial treatment to quickly suppress inflammation and thereby shorten the duration of active disease. In the following maintenance phase, prednisone is slowly tapered. Individualized dosing strategies are needed to optimize the tapering regime so as to shorten active disease duration and also prevent or minimize the cumulative negative effects of prednisone. This is the first study that found a negative correlation between younger age of onset and CRF in JDM. This may be explained by the possible negative effects of the inflammatory process and the pharmacological treatment on the maturation and development of skeletal muscle tissue. The precise effects of disease at young age are unknown, and therefore further studies are necessary.
In conclusion, this is the first study to show that both monocyclic and chronic JDM demonstrate declines in long-term trajectories of CRF and that there is insufficient evidence to prove that type of JDM influences these trajectories. Indeed, patients with both types of JDM showed initial improvement of CRF during the first years after diagnosis; however, no further improvements and even decreases in CRF were observed following this initial recovery phase. Longer disease duration, younger age of onset, and higher prednisone dose negatively influence CRF in the long term. This stresses the need for regular evaluation of CRF as an integrated part of clinical longterm follow-up, even in monocyclic patients who might currently be under-evaluated. Individually tailored exercise interventions to improve CRF are warranted in order to prevent long-term morbidity, physical dysfunction and work-related problems in adolescence and adulthood.
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